Tetra Bio-Pharma subsidiary Agro-Tek has signed an exclusive supply and distribution agreement with Engen Medical Corporation to distribute Engen’s Munchies B Gone gum in Canada.
Agro-Tek will have exclusive sales and distribution rights for the product in Canada for five years, under the agreement.
US-based Engen Medical Corporation owns global patent and intellectual property rights to a number of chewing gum products.
Canadian biopharmaceutical company ProMetic Life Sciences has raised C$21.05m ($16.13m) through the private placement of 4.4 million shares upon exercise of warrants by California Capital Equity.
The placement was priced at C$0.47 ($0.36) a share.
UK-based biotechnology company Nemaura Pharma has announced that it will raise £5m ($6.24m) in equity financing from private investors.
The company intends to use the funds to advance its Micro-Patch solid dose micro-needle system for a harmonic biologic, while part of them will also help accelerate its clinical programmes to prepare the drug-device combination for the market.
Canadian immunotherapy company Medicenna Therapeutics has announced that it intends to raise C$3.6m ($2.76m) in gross proceeds through a private placement of 1.8 million shares of its common stock in order to fund its non-clinical and clinical programmes, as well as meet working capital and general corporate needs.
The shares are priced at C$2 ($1.5) each.